Skip to main content
Top
Published in: Respiratory Research 1/2013

Open Access 01-12-2013 | Research

NF-κB activation in myeloid cells mediates ventilator-induced lung injury

Authors: Yi-An Ko, Ming-Chieh Yang, Hung-Tu Huang, Ching-Mei Hsu, Lee-Wei Chen

Published in: Respiratory Research | Issue 1/2013

Login to get access

Abstract

Background

Although use of the mechanical ventilator is a life-saving intervention, excessive tidal volumes will activate NF-κB in the lung with subsequent induction of lung edema formation, neutrophil infiltration and proinflammatory cytokine/chemokine release. The roles of NF-κB and IL-6 in ventilator-induced lung injury (VILI) remain widely debated.

Methods

To study the molecular mechanisms of the pathogenesis of VILI, mice with a deletion of IкB kinase in the myeloid cells (IKKβ△mye), IL-6-/- to WT chimeric mice, and C57BL/6 mice (WT) were placed on a ventilator for 6 hr.
WT mice were also given an IL-6-blocking antibody to examine the role of IL-6 in VILI.

Results

Our results revealed that high tidal volume ventilation induced pulmonary capillary permeability, neutrophil sequestration, macrophage drifting as well as increased protein in bronchoalveolar lavage fluid (BALF). IL-6 production and IL-1β, CXCR2, and MIP2 expression were also increased in WT lungs but not in those pretreated with IL-6-blocking antibodies. Further, ventilator-induced protein concentrations and total cells in BALF, as well as lung permeability, were all significantly decreased in IKKβ△mye mice as well as in IL6-/- to WT chimeric mice.

Conclusion

Given that IKKβ△mye mice demonstrated a significant decrease in ventilator-induced IL-6 production, we conclude that NF-κB–IL-6 signaling pathways induce inflammation, contributing to VILI, and IкB kinase in the myeloid cells mediates ventilator-induced IL-6 production, inflammation, and lung injury.
Appendix
Available only for authorised users
Literature
1.
go back to reference Budweiser S, Jorres RA, Pfeifer M: Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2008, 3 (4): 605-618.PubMedPubMedCentral Budweiser S, Jorres RA, Pfeifer M: Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2008, 3 (4): 605-618.PubMedPubMedCentral
2.
go back to reference Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR, Liles WC: Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest. 2006, 86 (8): 790-799. 10.1038/labinvest.3700440.PubMedCrossRef Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR, Liles WC: Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest. 2006, 86 (8): 790-799. 10.1038/labinvest.3700440.PubMedCrossRef
3.
go back to reference Damarla M, Hasan E, Boueiz A, Le A, Pae HH, Montouchet C, Kolb T, Simms T, Myers A, Kayyali US, et al: Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS One. 2009, 4 (2): e4600-10.1371/journal.pone.0004600.PubMedPubMedCentralCrossRef Damarla M, Hasan E, Boueiz A, Le A, Pae HH, Montouchet C, Kolb T, Simms T, Myers A, Kayyali US, et al: Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS One. 2009, 4 (2): e4600-10.1371/journal.pone.0004600.PubMedPubMedCentralCrossRef
4.
go back to reference Frank JA, Pittet JF, Wray C, Matthay MA: Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax. 2008, 63 (2): 147-153.PubMedCrossRef Frank JA, Pittet JF, Wray C, Matthay MA: Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax. 2008, 63 (2): 147-153.PubMedCrossRef
5.
go back to reference Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999, 159 (4 Pt 1): 1249-1256.PubMedCrossRef Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999, 159 (4 Pt 1): 1249-1256.PubMedCrossRef
6.
go back to reference Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG: Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med. 2005, 63 (10): 382-392.PubMed Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG: Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med. 2005, 63 (10): 382-392.PubMed
7.
go back to reference Dolinay T, Wu W, Kaminski N, Ifedigbo E, Kaynar AM, Szilasi M, Watkins SC, Ryter SW, Hoetzel A, Choi AM: Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One. 2008, 3 (2): e1601-10.1371/journal.pone.0001601.PubMedPubMedCentralCrossRef Dolinay T, Wu W, Kaminski N, Ifedigbo E, Kaynar AM, Szilasi M, Watkins SC, Ryter SW, Hoetzel A, Choi AM: Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One. 2008, 3 (2): e1601-10.1371/journal.pone.0001601.PubMedPubMedCentralCrossRef
8.
go back to reference Wolters PJ, Wray C, Sutherland RE, Kim SS, Koff J, Mao Y, Frank JA: Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol. 2009, 182 (12): 8056-8062. 10.4049/jimmunol.0801323.PubMedPubMedCentralCrossRef Wolters PJ, Wray C, Sutherland RE, Kim SS, Koff J, Mao Y, Frank JA: Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol. 2009, 182 (12): 8056-8062. 10.4049/jimmunol.0801323.PubMedPubMedCentralCrossRef
9.
go back to reference Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990, 10 (5): 2327-2334.PubMedPubMedCentralCrossRef Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990, 10 (5): 2327-2334.PubMedPubMedCentralCrossRef
11.
go back to reference Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, Li LF: Role for nuclear factor-kappaB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res. 2009, 154 (5): 228-240. 10.1016/j.trsl.2009.06.006.PubMedCrossRef Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, Li LF: Role for nuclear factor-kappaB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res. 2009, 154 (5): 228-240. 10.1016/j.trsl.2009.06.006.PubMedCrossRef
12.
go back to reference Held HD, Boettcher S, Hamann L, Uhlig S: Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. Am J Respir Crit Care Med. 2001, 163 (3 Pt 1): 711-716.PubMedCrossRef Held HD, Boettcher S, Hamann L, Uhlig S: Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. Am J Respir Crit Care Med. 2001, 163 (3 Pt 1): 711-716.PubMedCrossRef
13.
go back to reference Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005, 175 (6): 3463-3468.PubMedCrossRef Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005, 175 (6): 3463-3468.PubMedCrossRef
14.
go back to reference Barton BE: IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997, 85 (1): 16-20. 10.1006/clin.1997.4420.PubMedCrossRef Barton BE: IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997, 85 (1): 16-20. 10.1006/clin.1997.4420.PubMedCrossRef
15.
go back to reference Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000, 22 (5): 535-542. 10.1165/ajrcmb.22.5.3808.PubMedCrossRef Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000, 22 (5): 535-542. 10.1165/ajrcmb.22.5.3808.PubMedCrossRef
16.
go back to reference Frank JA, Parsons PE, Matthay MA: Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest. 2006, 130 (6): 1906-1914. 10.1378/chest.130.6.1906.PubMedPubMedCentralCrossRef Frank JA, Parsons PE, Matthay MA: Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest. 2006, 130 (6): 1906-1914. 10.1378/chest.130.6.1906.PubMedPubMedCentralCrossRef
17.
go back to reference Ramirez P, Ferrer M, Gimeno R, Tormo S, Valencia M, Piner R, Menendez R, Torres A: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med. 2009, 37 (5): 1691-1695. 10.1097/CCM.0b013e31819fec5f.PubMedCrossRef Ramirez P, Ferrer M, Gimeno R, Tormo S, Valencia M, Piner R, Menendez R, Torres A: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med. 2009, 37 (5): 1691-1695. 10.1097/CCM.0b013e31819fec5f.PubMedCrossRef
18.
go back to reference Jones SA, Rose-John S: The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta. 2002, 1592 (3): 251-263. 10.1016/S0167-4889(02)00319-1.PubMedCrossRef Jones SA, Rose-John S: The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta. 2002, 1592 (3): 251-263. 10.1016/S0167-4889(02)00319-1.PubMedCrossRef
19.
go back to reference Hegeman MA, Hennus MP, Heijnen CJ, Specht PA, Lachmann B, Jansen NJ, van Vught AJ, Cobelens PM: Ventilator-induced endothelial activation and inflammation in the lung and distal organs. Crit Care. 2009, 13 (6): R182-10.1186/cc8168.PubMedPubMedCentralCrossRef Hegeman MA, Hennus MP, Heijnen CJ, Specht PA, Lachmann B, Jansen NJ, van Vught AJ, Cobelens PM: Ventilator-induced endothelial activation and inflammation in the lung and distal organs. Crit Care. 2009, 13 (6): R182-10.1186/cc8168.PubMedPubMedCentralCrossRef
20.
go back to reference Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Goktuna SI, Neuenhahn M, Fierer J, Paxian S, et al: NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007, 130 (5): 918-931. 10.1016/j.cell.2007.07.009.PubMedPubMedCentralCrossRef Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Goktuna SI, Neuenhahn M, Fierer J, Paxian S, et al: NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007, 130 (5): 918-931. 10.1016/j.cell.2007.07.009.PubMedPubMedCentralCrossRef
21.
go back to reference Patterson CE, Rhoades RA, Garcia JG: Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol. 1992, 72 (3): 865-873. 10.1063/1.351760.PubMedCrossRef Patterson CE, Rhoades RA, Garcia JG: Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol. 1992, 72 (3): 865-873. 10.1063/1.351760.PubMedCrossRef
22.
go back to reference Renckens R, van Westerloo DJ, Roelofs JJ, Pater JM, Schultz MJ, Florquin S, van der Poll T: Acute phase response impairs host defense against pseudomonas aeruginosa pneumonia in mice. Crit Care Med. 2008, 36 (2): 580-587. 10.1097/01.CCM.0B013E3181620652.PubMedCrossRef Renckens R, van Westerloo DJ, Roelofs JJ, Pater JM, Schultz MJ, Florquin S, van der Poll T: Acute phase response impairs host defense against pseudomonas aeruginosa pneumonia in mice. Crit Care Med. 2008, 36 (2): 580-587. 10.1097/01.CCM.0B013E3181620652.PubMedCrossRef
23.
go back to reference Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM, et al: JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007, 6 (5): 386-397. 10.1016/j.cmet.2007.09.011.PubMedCrossRef Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM, et al: JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007, 6 (5): 386-397. 10.1016/j.cmet.2007.09.011.PubMedCrossRef
24.
go back to reference Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, Miyasaka K: Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med. 1997, 156 (1): 272-279. 10.1164/ajrccm.156.1.9607072.PubMedCrossRef Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, Miyasaka K: Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med. 1997, 156 (1): 272-279. 10.1164/ajrccm.156.1.9607072.PubMedCrossRef
25.
go back to reference Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998, 338 (6): 347-354. 10.1056/NEJM199802053380602.PubMedCrossRef Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998, 338 (6): 347-354. 10.1056/NEJM199802053380602.PubMedCrossRef
26.
go back to reference Oeckler RA, Hubmayr RD: Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J. 2007, 30 (6): 1216-1226. 10.1183/09031936.00104907.PubMedCrossRef Oeckler RA, Hubmayr RD: Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J. 2007, 30 (6): 1216-1226. 10.1183/09031936.00104907.PubMedCrossRef
27.
go back to reference Hsu LC, Enzler T, Seita J, Timmer AM, Lee CY, Lai TY, Yu GY, Lai LC, Temkin V, Sinzig U, et al: IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta. Nat Immunol. 2011, 12 (2): 144-150. 10.1038/ni.1976.PubMedPubMedCentralCrossRef Hsu LC, Enzler T, Seita J, Timmer AM, Lee CY, Lai TY, Yu GY, Lai LC, Temkin V, Sinzig U, et al: IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta. Nat Immunol. 2011, 12 (2): 144-150. 10.1038/ni.1976.PubMedPubMedCentralCrossRef
28.
go back to reference Liang B, Song Z, Wu B, Gardner D, Shealy D, Song XY, Wooley PH: Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis. J Inflamm (Lond). 2009, 6: 10-10.1186/1476-9255-6-10.CrossRef Liang B, Song Z, Wu B, Gardner D, Shealy D, Song XY, Wooley PH: Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis. J Inflamm (Lond). 2009, 6: 10-10.1186/1476-9255-6-10.CrossRef
Metadata
Title
NF-κB activation in myeloid cells mediates ventilator-induced lung injury
Authors
Yi-An Ko
Ming-Chieh Yang
Hung-Tu Huang
Ching-Mei Hsu
Lee-Wei Chen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2013
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-14-69

Other articles of this Issue 1/2013

Respiratory Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.